1. European Medicines Agency. Questions and answers on the suspension of rosiglitazone-containing medicines (Avandia, Avandamet and Avaglim). Outcome of a procedure under Article 20 of Regulation (EC) No. 726/2004. 2010.
2. Insulin resistance and atherosclerosis;Nigro;Endocr Rev.,2006
3. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD);Rydén;Eur Heart J.,2007
4. The metabolic syndrome and cardiovascular disease;Bonora;Ann Med.,2006
5. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus;Bolen;Ann Intern Med.,2007